Sign in to continue:

Thursday, March 12th, 2026

Comprehensive Loan Agreement Terms: Interest Rates, Covenants, and Lender Provisions Explained





Stoneridge, Inc. Announces Amendment to Credit Agreement and Revised Financial Covenants

Stoneridge, Inc. Announces Significant Amendments to Credit Agreement: Key Changes to Financial Covenants and Potential Impact on Shareholders

Date: March 11, 2026
Company: Stoneridge, Inc. (NYSE: SRI)

Overview

Stoneridge, Inc. has announced the execution of Amendment No. 3 to its Fifth Amended and Restated Credit Agreement, effective March 6, 2026. This amendment introduces material changes to the company’s financial covenants, leverage capacity, and borrowing terms. These updates are substantial and carry potential implications for shareholders and the company’s future financial flexibility.

Key Highlights of Amendment No. 3

  • Reduced Minimum Interest Coverage Ratios:

    • The minimum interest coverage ratio is reduced significantly for the upcoming quarters:
      • 1.60x for Q1 2026
      • 1.70x for Q2 2026
      • 1.75x for Q3 2026
      • Returns to 2.50x for Q4 2026 and thereafter
  • Increased Maximum Leverage Ratios:

    • The maximum leverage ratio is being increased, allowing the company to operate with higher leverage:
      • 3.75x for Q4 2025
      • 6.25x for Q1 2026
      • 6.75x for Q2 2026
      • 6.00x for Q3 2026
      • Returns to 4.00x for Q4 2026 and thereafter
  • Other Notable Changes:

    • On December 31, 2026, the current borrowing modifications and additions to affirmative covenants become effective.
    • Amendment No. 3 also includes further modifications and additions to affirmative covenants, though details are in the full agreement.
  • Incorporation by Reference:

    • The full text of Amendment No. 3 is filed as Exhibit 10.1 and is incorporated by reference into the current Form 8-K.

Why This Matters to Shareholders

  • Potential Impact on Financial Health and Flexibility:

    • The reduction in the interest coverage ratio and the increase in the maximum leverage ratio temporarily relax Stoneridge’s financial covenants. This could provide the company with greater flexibility to navigate short-term liquidity needs or operational challenges, but it also signals that the company may expect or be experiencing tighter financial conditions.
  • Risk Considerations:

    • Higher leverage ratios mean the company is permitted to take on more debt relative to earnings, which may increase financial risk and interest costs. Investors should closely monitor future quarterly results and any changes in credit ratings that may arise from these amendments.
  • Potential Price Sensitivity:

    • These changes are material and may influence investor perception of Stoneridge’s risk profile, cost of capital, and future earnings potential. Any indication of financial stress, or the need to relax covenants, can be a price-sensitive event and could impact the company’s share price, especially if the market interprets this as increased risk or signs of operational challenges.
  • Upcoming Deadlines and Reversions:

    • The covenants revert to their original, more stringent levels at the end of 2026, marking a clear deadline for management to normalize financial performance.

Signatory Details

The amendment was signed on behalf of Stoneridge, Inc. by Chief Financial Officer and Treasurer, Matthew R. Horvath, along with representatives from key lending institutions, including PNC Bank, National Association, Bank of America, N.A., JPMorgan Chase Bank, N.A., First Merchants Bank, and BMO Bank, N.A.

Conclusion

The relaxation of key financial covenants and increased borrowing flexibility are significant developments for Stoneridge, Inc. shareholders. These changes are likely to be closely watched by the market and could impact the company’s share price depending on investor interpretation of the company’s financial health and future prospects.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review the company’s official filings and consult their financial advisors before making any investment decisions. The author and publisher assume no responsibility for any actions taken based on this information.




View STONERIDGE INC Historical chart here



First Guaranty Bancshares Sells Texas Branches to Armstrong Bank in $270 Million Deal

First Guaranty Bancshares Announces Strategic Exit from Texa...

Biofrontera Reports Positive Phase 2b Results for Ameluz® Photodynamic Therapy in Moderate to Severe Acne Vulgaris 1

Biofrontera Inc. Reports Positive Phase 2b Results for Amelu...

   Ad